News AZ and Oracle team up on AI platform for clinical trials AstraZeneca has launched a project with tech giant Oracle that will use AI and real-world data to improve clinical research and patient care.
News AI in drug discovery & development: News watch, October 2026 Recent news in biopharma AI include a $1.5bn partnership between AstraZeneca and insitro, plus news from Iambic, DaltonTx, NVIDIA, and Chai Discovery.
News MHRA lays out its thinking on AI and medicines regulation An MHRA document explaining how regulations will adapt to the era of AI and personalised medicine has been well received by the pharma industry.
News Zealand forges obesity alliance with AI specialist Generate Zealand has added another strand to its programme of weight-loss drug development, linking with AI player Generate on multispecific protein therapies.
News Biohub raises $1.8bn for its 'virtual biology' initiative Just months after launching an open-source 'virtual biology' platform, Biohub has raised $1.8 billion in backing for the AI-powered initiative.
News UK backs all health AI proposals in commission report The UK will accept all 44 proposals made in a recent report on using AI tools in the NHS, including continuous monitoring after deployment.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.